Njord International AB has signed an exclusive distribution agreement with Inframed Medical Equipment to commercialise Njord’s novel patient transfer solution Atle® 180. This partnership unites Njord Medtech's cutting-edge medical technology with Inframed's strong relationships and experience in the Israeli healthcare market
Established in 2011, Inframed is a leading distributor of medical devices in the local healthcare sector continuously introducing and serving their customers with novel-, added value-, state of the art medical technologies. The main focus resides within medical imaging, interventional radiology, and diagnostic cardiology.
“The minute we showed the Atle system to our potential customers - radiology and cardiology departments - enthusiasm is the only word to describe it best. Finally our backs will no longer hurt and the work will be much easier and faster, they unanimously said. We look forward to great success with these hard working medical providers.” says Dvora Schwarz, CEO Inframed Medical Equipment
“We truly look forward to join forces with Dvora and the strong team at Inframed. Their trust based approach and proven track record of introducing novel medical devices are key capabilities to leverage while introducing Atle 180, creating a more resilient acute care operating model for ongoing sector challenges” says Jacob Ahrnstein, CEO Njord Medtech
Atle® 180 will be introduced to the Israeli market during the autumn of 2024.
For further information, please contact: hello@njordmedtech.com
Inframed Medical Equipment is a leading medical device distributor in the Israeli market established in 2011. With a mission to contribute to the advancement of the healthcare system in Israel Inframed has continuously introduced and served customers with state of the art medical technologies.
Njord Medtech® is set on a mission to solve unmet needs in radiology and patient handling for a resilient and sustainable healthcare sector. The company is dedicated to improving patient care and healthcare efficiency with a focus on bringing forward co-bot solutions. At its inception, the company was incubated at Sahlgrenska University Hospital, Sweden.